Tired Of Fighting For Resources? Set Up Your Own Foundation

Six years ago, neurologist J. William Langston stumbled onto an exciting discovery, a contaminated synthetic heroin that seemed to trigger symptoms of Parkinson's disease. Almost overnight, Langston was thrust into the limelight. Reporters flocked to his office. Foundations invited him to apply for grants. His lab began reporting steady progress in the long struggle toward a cure for Parkinson's, a degenerative disease that affects half a million people in the United States. But success brought

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

But success brought problems as well as accolades. First Langston had to find space to carry out his research; then his initial round of grants ran out, and he began to worry about the precarious nature of his funding. So he took the bold step of striking out on his, own. He left the faculty of Stanford University, severed his ties with the Santa Clara Valley Medical Center and, in April, started his own organization, the California Foundation for Parkinson's Disease and Related Disorders, to support his research.

Although it's too soon to tell if the foundation will survive and prosper, Langston sees it as a model for other scientists whose research outgrows the ability of their institutions to support it—a problem he suspects will increasingly crop up in rapidly expanding fields such as neuroscience.

This problem was outlined last year by David H. Cohen, vice president for research at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Glennda Chui

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours